HuGE Literature Finder
Records 1-30
|
Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it?
Brain pathology (Zurich, Switzerland) 2020 Jul . Vaubel Rachael, Zschernack Valentina, Tran Quynh T, Jenkins Sarah, Caron Alissa, Milosevic Dragana, Smadbeck James, Vasmatzis George, Kandels Daniela, Gnekow Astrid, Kramm Christof, Jenkins Robert, Kipp Benjamin R, Rodriguez Fausto J, Orr Brent A, Pietsch Torsten, Giannini Cateri |
|
Landscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma.
Cellular and molecular neurobiology 2020 Jun . Carlos-Escalante José Alberto, Gómez-Flores-Ramos Liliana, Bian Xiaopeng, Perdomo-Pantoja Alexander, de Andrade Kelvin César, Mejía-Pérez Sonia Iliana, Cacho-Díaz Bernardo, González-Barrios Rodrigo, Reynoso-Noverón Nancy, Soto-Reyes Ernesto, Sánchez-Correa Thalía Estefanía, Guerra-Calderas Lissania, Yan Chunhua, Chen Qingrong, Castro-Hernández Clementina, Vidal-Millán Silvia, Taja-Chayeb Lucía, Gutiérrez Olga, Álvarez-Gómez Rosa María, Gómez-Amador Juan Luis, Ostrosky-Wegman Patricia, Mohar-Betancourt Alejandro, Herrera-Montalvo Luis Alonso, Corona Teresa, Meerzaman Daoud, Wegman-Ostrosky Tal |
|
Germline cancer predisposition variants and pediatric glioma: a population-based study in California.
Neuro-oncology 2020 Jan . Muskens Ivo S, de Smith Adam J, Zhang Chenan, Hansen Helen M, Morimoto Libby, Metayer Catherine, Ma Xiaomei, Walsh Kyle M, Wiemels Joseph |
|
High frequency of H3K27M immunopositivity in adult thalamic glioblastoma.
Neuropathology : official journal of the Japanese Society of Neuropathology 2019 Apr 39 (2): 78-84. Rao Shilpa, Kanuri Nandaki N, Nimbalkar Vidya, Arivazhagan Arimappamagan, Santosh Va |
|
The genetic landscape of anaplastic pleomorphic xanthoastrocytoma.
Brain pathology (Zurich, Switzerland) 2019 Jan 29 (1): 85-96. Phillips Joanna J, Gong Henry, Chen Katharine, Joseph Nancy M, van Ziffle Jessica, Bastian Boris C, Grenert James P, Kline Cassie N, Mueller Sabine, Banerjee Anuradha, Nicolaides Theodore, Gupta Nalin, Berger Mitchel S, Lee Han S, Pekmezci Melike, Tihan Tarik, Bollen Andrew W, Perry Arie, Shieh Joseph T C, Solomon David |
|
Granular cell astrocytoma: an aggressive IDH-wildtype diffuse gliomarwith molecular genetic features of primary glioblastoma.
Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto |
|
Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing.
Journal of neuropathology and experimental neurology 2018 Aug 77 (8): 710-716. Cantero Diana, Rodríguez de Lope Ángel, Moreno de la Presa Raquel, Sepúlveda Juan M, Borrás José M, Castresana Javier S, D'Haene Nicky, García Juan F, Salmon Isabelle, Mollejo Manuela, Rey Juan A, Hernández-Laín Aurelio, Meléndez Bárba |
|
IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis.
Cancer science 2018 May . Otani Ryohei, Uzuka Takeo, Higuchi Fumi, Matsuda Hadzki, Nomura Masashi, Tanaka Shota, Mukasa Akitake, Ichimura Koichi, Kim Phyo, Ueki Keisu |
|
The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma.
Journal of neuro-oncology 2017 Sep . Liu Xiang, Mangla Rajiv, Tian Wei, Qiu Xing, Li Dongmei, Walter Kevin A, Ekholm Sven, Johnson Mahlon |
|
The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types.
Oncotarget 2017 Jan . Fancello Laura, Kampen Kim R, Hofman Isabel Jf, Verbeeck Jelle, De Keersmaecker K |
|
GBM-associated mutations and altered protein expression are more common in young patients.
Oncotarget 2016 Aug . Ferguson Sherise D, Xiu Joanne, Weathers Shiao-Pei, Zhou Shouhao, Kesari Santosh, Weiss Stephanie E, Verhaak Roeland G, Hohl Raymond J, Barger Geoffrey R, Reddy Sandeep K, Heimberger Amy |
|
TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma.
Oncotarget 2016 Jun . Mascelli Samantha, Nozza Paolo, Jones David T W, Colin Carole, Pistorio Angela, Milanaccio Claudia, Ravegnani Marcello, Consales Alessandro, Witt Olaf, Morana Giovanni, Cama Armando, Capra Valeria, Biassoni Roberto, Pfister Stefan M, Figarella-Branger Dominique, Garrè Maria Luisa, Raso Alessand |
|
Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics.
Acta neuropathologica communications 2016 4 (1): 1. Hoffman Lindsey M, DeWire Mariko, Ryall Scott, Buczkowicz Pawel, Leach James, Miles Lili, Ramani Arun, Brudno Michael, Kumar Shiva Senthil, Drissi Rachid, Dexheimer Phillip, Salloum Ralph, Chow Lionel, Hummel Trent, Stevenson Charles, Lu Q Richard, Jones Blaise, Witte David, Aronow Bruce, Hawkins Cynthia E, Fouladi Mary |
|
ATRX loss in adult supratentorial diffuse astrocytomas correlates with p53 over expression and IDH1 mutation and predicts better outcome in p53 accumulated patients.
Histology and histopathology 2015 Sep 11664. Shao Li-Wei, Pan Yi, Qi Xue-Ling, Li Yong-Xiao, Ma Xiao-Long, Yi Wei-Ning, Zhang Jing, Zhong Yan-Feng, Chang Qi |
|
Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics.
Oncotarget 2015 Sep . Li Rui, Chen Xincheng, You Yongping, Wang Xiefeng, Liu Yanwei, Hu Qi, Yan W |
|
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
|
Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas.
Neuropathology : official journal of the Japanese Society of Neuropathology 2015 Aug 35 (4): 324-35. Ogura Ryosuke, Tsukamoto Yoshihiro, Natsumeda Manabu, Isogawa Mizuho, Aoki Hiroshi, Kobayashi Tsutomu, Yoshida Seiichi, Okamoto Kouichiro, Takahashi Hitoshi, Fujii Yukihiko, Kakita Akiyos |
|
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
The New England journal of medicine 2015 Jun 372 (26): 2481-98. , Brat Daniel J, Verhaak Roel G W, Aldape Kenneth D, Yung W K Alfred, Salama Sofie R, Cooper Lee A D, Rheinbay Esther, Miller C Ryan, Vitucci Mark, Morozova Olena, Robertson A Gordon, Noushmehr Houtan, Laird Peter W, Cherniack Andrew D, Akbani Rehan, Huse Jason T, Ciriello Giovanni, Poisson Laila M, Barnholtz-Sloan Jill S, Berger Mitchel S, Brennan Cameron, Colen Rivka R, Colman Howard, Flanders Adam E, Giannini Caterina, Grifford Mia, Iavarone Antonio, Jain Rajan, Joseph Isaac, Kim Jaegil, Kasaian Katayoon, Mikkelsen Tom, Murray Bradley A, O'Neill Brian Patrick, Pachter Lior, Parsons Donald W, Sougnez Carrie, Sulman Erik P, Vandenberg Scott R, Van Meir Erwin G, von Deimling Andreas, Zhang Hailei, Crain Daniel, Lau Kevin, Mallery David, Morris Scott, Paulauskis Joseph, Penny Robert, Shelton Troy, Sherman Mark, Yena Peggy, Black Aaron, Bowen Jay, Dicostanzo Katie, Gastier-Foster Julie, Leraas Kristen M, Lichtenberg Tara M, Pierson Christopher R, Ramirez Nilsa C, Taylor Cynthia, Weaver Stephanie, Wise Lisa, Zmuda Erik, Davidsen Tanja, Demchok John A, Eley Greg, Ferguson Martin L, Hutter Carolyn M, Mills Shaw Kenna R, Ozenberger Bradley A, Sheth Margi, Sofia Heidi J, Tarnuzzer Roy, Wang Zhining, Yang Liming, Zenklusen Jean Claude, Ayala Brenda, Baboud Julien, Chudamani Sudha, Jensen Mark A, Liu Jia, Pihl Todd, Raman Rohini, Wan Yunhu, Wu Ye, Ally Adrian, Auman J Todd, Balasundaram Miruna, Balu Saianand, Baylin Stephen B, Beroukhim Rameen, Bootwalla Moiz S, Bowlby Reanne, Bristow Christopher A, Brooks Denise, Butterfield Yaron, Carlsen Rebecca, Carter Scott, Chin Lynda, Chu Andy, Chuah Eric, Cibulskis Kristian, Clarke Amanda, Coetzee Simon G, Dhalla Noreen, Fennell Tim, Fisher Sheila, Gabriel Stacey, Getz Gad, Gibbs Richard, Guin Ranabir, Hadjipanayis Angela, Hayes D Neil, Hinoue Toshinori, Hoadley Katherine, Holt Robert A, Hoyle Alan P, Jefferys Stuart R, Jones Steven, Jones Corbin D, Kucherlapati Raju, Lai Phillip H, Lander Eric, Lee Semin, Lichtenstein Lee, Ma Yussanne, Maglinte Dennis T, Mahadeshwar Harshad S, Marra Marco A, Mayo Michael, Meng Shaowu, Meyerson Matthew L, Mieczkowski Piotr A, Moore Richard A, Mose Lisle E, Mungall Andrew J, Pantazi Angeliki, Parfenov Michael, Park Peter J, Parker Joel S, Perou Charles M, Protopopov Alexei, Ren Xiaojia, Roach Jeffrey, Sabedot Thaís S, Schein Jacqueline, Schumacher Steven E, Seidman Jonathan G, Seth Sahil, Shen Hui, Simons Janae V, Sipahimalani Payal, Soloway Matthew G, Song Xingzhi, Sun Huandong, Tabak Barbara, Tam Angela, Tan Donghui, Tang Jiabin, Thiessen Nina, Triche Timothy, Van Den Berg David J, Veluvolu Umadevi, Waring Scot, Weisenberger Daniel J, Wilkerson Matthew D, Wong Tina, Wu Junyuan, Xi Liu, Xu Andrew W, Yang Lixing, Zack Travis I, Zhang Jianhua, Aksoy B Arman, Arachchi Harindra, Benz Chris, Bernard Brady, Carlin Daniel, Cho Juok, DiCara Daniel, Frazer Scott, Fuller Gregory N, Gao JianJiong, Gehlenborg Nils, Haussler David, Heiman David I, Iype Lisa, Jacobsen Anders, Ju Zhenlin, Katzman Sol, Kim Hoon, Knijnenburg Theo, Kreisberg Richard Bailey, Lawrence Michael S, Lee William, Leinonen Kalle, Lin Pei, Ling Shiyun, Liu Wenbin, Liu Yingchun, Liu Yuexin, Lu Yiling, Mills Gordon, Ng Sam, Noble Michael S, Paull Evan, Rao Arvind, Reynolds Sheila, Saksena Gordon, Sanborn Zack, Sander Chris, Schultz Nikolaus, Senbabaoglu Yasin, Shen Ronglai, Shmulevich Ilya, Sinha Rileen, Stuart Josh, Sumer S Onur, Sun Yichao, Tasman Natalie, Taylor Barry S, Voet Doug, Weinhold Nils, Weinstein John N, Yang Da, Yoshihara Kosuke, Zheng Siyuan, Zhang Wei, Zou Lihua, Abel Ty, Sadeghi Sara, Cohen Mark L, Eschbacher Jenny, Hattab Eyas M, Raghunathan Aditya, Schniederjan Matthew J, Aziz Dina, Barnett Gene, Barrett Wendi, Bigner Darell D, Boice Lori, Brewer Cathy, Calatozzolo Chiara, Campos Benito, Carlotti Carlos Gilberto, Chan Timothy A, Cuppini Lucia, Curley Erin, Cuzzubbo Stefania, Devine Karen, DiMeco Francesco, Duell Rebecca, Elder J Bradley, Fehrenbach Ashley, Finocchiaro Gaetano, Friedman William, Fulop Jordonna, Gardner Johanna, Hermes Beth, Herold-Mende Christel, Jungk Christine, Kendler Ady, Lehman Norman L, Lipp Eric, Liu Ouida, Mandt Randy, McGraw Mary, Mclendon Roger, McPherson Christopher, Neder Luciano, Nguyen Phuong, Noss Ardene, Nunziata Raffaele, Ostrom Quinn T, Palmer Cheryl, Perin Alessandro, Pollo Bianca, Potapov Alexander, Potapova Olga, Rathmell W Kimryn, Rotin Daniil, Scarpace Lisa, Schilero Cathy, Senecal Kelly, Shimmel Kristen, Shurkhay Vsevolod, Sifri Suzanne, Singh Rosy, Sloan Andrew E, Smolenski Kathy, Staugaitis Susan M, Steele Ruth, Thorne Leigh, Tirapelli Daniela P C, Unterberg Andreas, Vallurupalli Mahitha, Wang Yun, Warnick Ronald, Williams Felicia, Wolinsky Yingli, Bell Sue, Rosenberg Mara, Stewart Chip, Huang Franklin, Grimsby Jonna L, Radenbaugh Amie J, Zhang Jian |
|
Gene mutation profiling of primary glioblastoma through multiple tumor biopsy guided by 1H-magnetic resonance spectroscopy.
International journal of clinical and experimental pathology 2015 8 (5): 5327-35. Tang Chao, Guo Jun, Chen Hong, Yao Cheng-Jun, Zhuang Dong-Xiao, Wang Yin, Tang Wei-Jun, Ren Guang, Yao Yu, Wu Jin-Song, Mao Ying, Zhou Liang- |
|
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Jun 20 (11): 2898-909. Wakimoto Hiroaki, Tanaka Shota, Curry William T, Loebel Franziska, Zhao Dan, Tateishi Kensuke, Chen Juxiang, Klofas Lindsay K, Lelic Nina, Kim James C, Dias-Santagata Dora, Ellisen Leif W, Borger Darrell R, Fendt Sarah-Maria, Vander Heiden Matthew G, Batchelor Tracy T, Iafrate A John, Cahill Daniel P, Chi Andrew |
|
TP53 promoter methylation in primary glioblastoma: relationship with TP53 mRNA and protein expression and mutation status.
DNA and cell biology 2014 Apr 33 (4): 217-26. Jesionek-Kupnicka Dorota, Szybka Malgorzata, Malachowska Beata, Fendler Wojciech, Potemski Piotr, Piaskowski Sylwester, Jaskolski Dariusz, Papierz Wielislaw, Skowronski Wieslaw, Och Waldemar, Kordek Radzislaw, Zawlik Izabe |
|
IDH1/IDH2 but not TP53 mutations predict prognosis in Bulgarian glioblastoma patients.
BioMed research international 2014 2014 654727. Stancheva Gergana, Goranova Teodora, Laleva Maria, Kamenova Margarita, Mitkova Atanaska, Velinov Nikolay, Poptodorov George, Mitev Vanio, Kaneva Radka, Gabrovsky Nikol |
|
Prognostic value of MGMT promoter methylation and TP53 mutation in glioblastomas depends on IDH1 mutation.
Asian Pacific journal of cancer prevention : APJCP 2014 15 (24): 10893-8. Wang Kai, Wang Yin-Yan, Ma Jun, Wang Jiang-Fei, Li Shao-Wu, Jiang Tao, Dai Jian-Pi |
|
TERT promoter mutations in primary and secondary glioblastomas.
Acta neuropathologica 2013 Dec 126 (6): 931-7. Nonoguchi Naosuke, Ohta Takashi, Oh Ji-Eun, Kim Young-Ho, Kleihues Paul, Ohgaki Hiro |
|
P53 codon 72 Arg/Pro polymorphism and glioma risk: an updated meta-analysis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Oct 34 (5): 3121-30. He Fang, Xia Yi, Liu Huafeng, Li Jin, Wang Ch |
|
Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Sep 19 (18): 5146-57. Hartmann Christian, Hentschel Bettina, Simon Matthias, Westphal Manfred, Schackert Gabriele, Tonn Jörg C, Loeffler Markus, Reifenberger Guido, Pietsch Torsten, von Deimling Andreas, Weller Michael, |
|
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas.
Oncogene 2013 Jun 32 (25): 3091-100. Wang P, Dong Q, Zhang C, Kuan P-F, Liu Y, Jeck W R, Andersen J B, Jiang W, Savich G L, Tan T-X, Auman J T, Hoskins J M, Misher A D, Moser C D, Yourstone S M, Kim J W, Cibulskis K, Getz G, Hunt H V, Thorgeirsson S S, Roberts L R, Ye D, Guan K-L, Xiong Y, Qin L-X, Chiang D |
|
Clinicopathological features and molecular analysis of primary glioblastomas in Moroccan patients.
Journal of molecular neuroscience : MN 2013 Mar 49 (3): 567-73. Hilmani Said, Abidi Omar, Benrahma Houda, Karkouri Mehdi, Sahraoui Souha, El Azhari Abdessamad, Barakat Abdelham |
|
Secondary glioblastomas with IDH1/2 mutations have longer glioma history from preceding lower-grade gliomas.
Brain tumor pathology 2013 Mar . Ohno M, Narita Y, Miyakita Y, Matsushita Y, Yoshida A, Fukushima S, Ichimura K, Shibui S |
|
CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry.
Neuropathology : official journal of the Japanese Society of Neuropathology 2013 Jan . Purkait S, Jha P, Sharma MC, Suri V, Sharma M, Kale SS, Sarkar C |
|
Screening for EGFR amplifications with a novel method and their significance for the outcome of glioblastoma patients.
PloS one 2013 8 (6): e65444. Bie?kowski Micha?, Piaskowski Sylwester, Stoczy?ska-Fidelus Ewelina, Szybka Ma?gorzata, Banaszczyk Mateusz, Witusik-Perkowska Monika, Jesie?-Lewandowicz Emilia, Jaskólski Dariusz J, Radomiak-Za?uska Anna, Jesionek-Kupnicka Dorota, Sikorska Beata, Papierz Wielis?aw, Rieske Piotr, Liberski Pawe? |
|
IDH1 mutation of gliomas with long-term survival analysis.
Oncology reports 2012 Nov 28 (5): 1639-44. Myung Jae Kyung, Cho Hwa Jin, Park Chul-Kee, Kim Seung-Ki, Phi Ji Hoon, Park Sung-H |
|
TP53 mutations in astrocytic gliomas: an association with histological grade, TP53 codon 72 polymorphism and p53 expression.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2012 Nov 120 (11): 882-9. Faria Mario H G, Neves Filho Eduardo H C, Alves Markenia K S, Burbano Rommel M R, de Moraes Filho Manoel O, Rabenhorst Silvia H |
|
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.
Nature 2012 Feb 482 (7384): 226-31. Schwartzentruber Jeremy, Korshunov Andrey, Liu Xiao-Yang, Jones David T W, Pfaff Elke, Jacob Karine, Sturm Dominik, Fontebasso Adam M, Quang Dong-Anh Khuong, Tönjes Martje, Hovestadt Volker, Albrecht Steffen, Kool Marcel, Nantel Andre, Konermann Carolin, Lindroth Anders, Jäger Natalie, Rausch Tobias, Ryzhova Marina, Korbel Jan O, Hielscher Thomas, Hauser Peter, Garami Miklos, Klekner Almos, Bognar Laszlo, Ebinger Martin, Schuhmann Martin U, Scheurlen Wolfram, Pekrun Arnulf, Frühwald Michael C, Roggendorf Wolfgang, Kramm Christoph, Dürken Matthias, Atkinson Jeffrey, Lepage Pierre, Montpetit Alexandre, Zakrzewska Magdalena, Zakrzewski Krzystof, Liberski Pawel P, Dong Zhifeng, Siegel Peter, Kulozik Andreas E, Zapatka Marc, Guha Abhijit, Malkin David, Felsberg Jörg, Reifenberger Guido, von Deimling Andreas, Ichimura Koichi, Collins V Peter, Witt Hendrik, Milde Till, Witt Olaf, Zhang Cindy, Castelo-Branco Pedro, Lichter Peter, Faury Damien, Tabori Uri, Plass Christoph, Majewski Jacek, Pfister Stefan M, Jabado Na |
|
IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma.
Cancer science 2012 Feb 103 (2): 269-73. SongTao Qi, Lei Yu, Si Gui, YanQing Ding, HuiXia Han, XueLin Zhang, LanXiao Wu, Fei Y |
|
IDH1 mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival.
Cancer 2012 Jan 118 (2): 452-60. Thon Niklas, Eigenbrod Sabina, Kreth Simone, Lutz Juergen, Tonn Joerg-Christian, Kretzschmar Hans, Peraud Aurelia, Kreth Friedrich-Wilhe |
|
Characterization of molecular genetic alterations in GBMs highlights a distinctive molecular profile in young adults.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2011 Dec 20 (4): 225-32. Jha Prerana, Suri Vaishali, Singh Geetika, Jha Pankaj, Purkait Suvendu, Pathak Pankaj, Sharma Vikas, Sharma Mehar Chand, Suri Ashish, Gupta Deepak, Mahapatra Ashok Kumar, Sarkar Chit |
|
Molecular markers in low-grade gliomas: predictive or prognostic?
Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Jul 17 (13): 4588-99. Hartmann Christian, Hentschel Bettina, Tatagiba Marcos, Schramm Johannes, Schnell Oliver, Seidel Clemens, Stein Robert, Reifenberger Guido, Pietsch Torsten, von Deimling Andreas, Loeffler Markus, Weller Michael, |
|
Benefits of interferon-? and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: A multicenter study.
Cancer 2011 Apr 117 (8): 1721-30. Motomura Kazuya, Natsume Atsushi, Kishida Yugo, Higashi Hiroyuki, Kondo Yutaka, Nakasu Yoko, Abe Tatsuya, Namba Hiroki, Wakai Kenji, Wakabayashi Toshihi |
|
First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response.
Neuro-oncology 2011 Feb 13 (2): 235-41. Taal Walter, Dubbink Hendrikus J, Zonnenberg Chris B L, Zonnenberg Bernard A, Postma Tjeerd J, Gijtenbeek Johanna M M, Boogerd Willem, Groenendijk Floris H, Kros Johan M, Kouwenhoven Mathilde C M, van Marion Ronald, van Heuvel Irene, van der Holt Bronno, Bromberg Jacoline E C, Sillevis Smitt Peter A E, Dinjens Winand N M, van den Bent Martin J, |
|
MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation.
Journal of neuro-oncology 2011 Feb 101 (3): 405-17. Groenendijk Floris H, Taal Walter, Dubbink Hendrikus J, Haarloo Cathleen R, Kouwenhoven Mathilde C, van den Bent Martin J, Kros Johan M, Dinjens Winand N |
|
Molecular classification of low-grade diffuse gliomas.
The American journal of pathology 2010 Dec 177 (6): 2708-14. Kim Young-Ho, Nobusawa Sumihito, Mittelbronn Michel, Paulus Werner, Brokinkel Benjamin, Keyvani Kathy, Sure Ulrich, Wrede Karsten, Nakazato Yoichi, Tanaka Yuko, Vital Anne, Mariani Luigi, Stawski Robert, Watanabe Takuya, De Girolami Umberto, Kleihues Paul, Ohgaki Hiro |
|
p53 abnormality and tumor invasion in patients with malignant astrocytoma.
Brain tumor pathology 2010 Oct 27 (2): 95-101. Momota Hiroyuki, Narita Yoshitaka, Matsushita Yuko, Miyakita Yasuji, Shibui Soichi |
|
Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas.
Journal of neuro-oncology 2010 Sep 99 (2): 209-15. Antonelli Manila, Buttarelli Francesca Romana, Arcella Antonietta, Nobusawa Sumihito, Donofrio Vittoria, Oghaki Hiroko, Giangaspero Feli |
|
Giant cell glioblastoma is associated with altered aurora b expression and concomitant p53 mutation.
Journal of neuropathology and experimental neurology 2010 Jun 69 (6): 632-42. Temme Achim, Geiger Kathrin D, Wiedemuth Ralf, Conseur Katharina, Pietsch Torsten, Felsberg Jörg, Reifenberger Guido, Tatsuka Masaaki, Hagel Christian, Westphal Manfred, Berger Hilmar, Simon Matthias, Weller Michael, Schackert Gabrie |
|
Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Dec 27 (34): 5743-50. Weller Michael, Felsberg Jörg, Hartmann Christian, Berger Hilmar, Steinbach Joachim P, Schramm Johannes, Westphal Manfred, Schackert Gabriele, Simon Matthias, Tonn Jörg C, Heese Oliver, Krex Dietmar, Nikkhah Guido, Pietsch Torsten, Wiestler Otmar, Reifenberger Guido, von Deimling Andreas, Loeffler Mark |
|
Long-term survivors of glioblastoma: clinical features and molecular analysis.
Acta neurochirurgica 2009 Nov 151 (11): 1349-58. Sonoda Yukihiko, Kumabe Toshihiro, Watanabe Mika, Nakazato Yoichi, Inoue Tomoo, Kanamori Masayuki, Tominaga Tei |
|
Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Nov 15 (21): 6683-93. Felsberg Jörg, Rapp Marion, Loeser Simon, Fimmers Rolf, Stummer Walter, Goeppert Matthias, Steiger Hans-Jacob, Friedensdorf Britta, Reifenberger Guido, Sabel Michael |
|
Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma.
Cancer investigation 2009 Oct 27 (8): 825-9. Shamsara Jamal, Sharif Samaneh, Afsharnezhad Sima, Lotfi Marzieh, Raziee Hamid Reza, Ghaffarzadegan Kamran, Moradi Afshin, Rahighi Saeed, Behravan Jav |
|
IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas.
Neuro-oncology 2009 Aug 11 (4): 341-7. Ichimura Koichi, Pearson Danita M, Kocialkowski Sylvia, Bäcklund L Magnus, Chan Raymond, Jones David T W, Collins V Pet |
|
Common polymorphisms in the MDM2 and TP53 genes and the relationship between TP53 mutations and patient outcomes in glioblastomas.
Brain pathology (Zurich, Switzerland) 2009 Apr 19 (2): 188-94. Zawlik Izabela, Kita Daisuke, Vaccarella Salvatore, Mittelbronn Michel, Franceschi Silvia, Ohgaki Hiro |
|
IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas.
The American journal of pathology 2009 Apr 174 (4): 1149-53. Watanabe Takuya, Nobusawa Sumihito, Kleihues Paul, Ohgaki Hiro |
|
Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations.
Journal of neuropathology and experimental neurology 2009 Feb 68 (2): 210-5. Watanabe Takuya, Nobusawa Sumihito, Lu Shengqing, Huang Jian, Mittelbronn Michel, Ohgaki Hiro |
|
Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration.
American journal of clinical pathology 2009 Feb 131 (2): 257-63. Ruano Yolanda, Ribalta Teresa, de Lope Angel Rodríguez, Campos-Martín Yolanda, Fiaño Concepción, Pérez-Magán Elisa, Hernández-Moneo José-Luis, Mollejo Manuela, Meléndez Bárba |
|
High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations.
Cancer genetics and cytogenetics 2009 Jan 188 (2): 77-82. Jesien-Lewandowicz Emilia, Jesionek-Kupnicka Dorota, Zawlik Izabela, Szybka Ma?gorzata, Kulczycka-Wojdala Dominika, Rieske Piotr, Sieruta Monika, Jaskolski Dariusz, Och Waldemar, Skowronski Wies?aw, Sikorska Beata, Potemski Piotr, Papierz Wielislaw, Liberski Pawel P, Kordek Radzis? |
|
TP53 codon 72 polymorphism is associated with age at onset of glioblastoma.
Neurology 2009 Jan 72 (4): 332-6. El Hallani S, Ducray F, Idbaih A, Marie Y, Boisselier B, Colin C, Laigle-Donadey F, Rodéro M, Chinot O, Thillet J, Hoang-Xuan K, Delattre J-Y, Sanson |
|
Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study.
Neuroepidemiology 2009 32 (1): 21-9. Zawlik Izabela, Vaccarella Salvatore, Kita Daisuke, Mittelbronn Michel, Franceschi Silvia, Ohgaki Hiro |
|
The role of a single nucleotide polymorphism of MDM2 in glioblastoma multiforme.
Journal of neurosurgery 2008 Nov 109 (5): 842-8. Khatri Rina G, Navaratne Kapila, Weil Robert |
|
[Mutations of p53 gene in 41 cases of human brain gliomas].
Ai zheng = Aizheng = Chinese journal of cancer 2008 Jan 27 (1): 8-11. Cui Wen, Kong Xia, Cao Hui-Ling, Wang Xu, Gao Ji-Fa, Wu Ren-Liang, Wang Xue-Ch |
|
TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors.
Cancer genetics and cytogenetics 2007 Sep 177 (2): 103-7. Idbaih Ahmed, Boisselier Blandine, Marie Yannick, El Hallani Soufiane, Sanson Marc, Crinière Emmanuelle, Rodero Mathieu, Carpentier Catherine, Paris Sophie, Laigle-Donadey Florence, Ducray François, Hoang-Xuan Khê, Delattre Jean-Yv |
|
Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Jul 14 (7): 1774-83. Wiencke John K, Aldape Kenneth, McMillan Alex, Wiemels Joe, Moghadassi Michelle, Miike Rei, Kelsey Karl T, Patoka Joe, Long Jeff, Wrensch Margar |
|
Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas.
Brain research. Molecular brain research 2005 Jun 137 (1-2): 98-103. Parhar Preeti, Ezer Rona, Shao Yongzhao, Allen Jeffrey C, Miller Douglas C, Newcomb Elizabeth |
|
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.
Journal of the National Cancer Institute 2001 Aug 93 (16): 1246-56. Smith J S, Tachibana I, Passe S M, Huntley B K, Borell T J, Iturria N, O'Fallon J R, Schaefer P L, Scheithauer B W, James C D, Buckner J C, Jenkins R |
|
MGMT gene promoter methylation and its correlation with clinicopathological parameters in glioblastomas.
Neurology India 0 66 (4): 1106-1114. Arora Iteeka, Gurav Mamta, Rumde Rachna, Dhanavade Sandeep, Kadam Vinayak, Kurani Hetakshi, Shetty Omshree, Goda Jayant Sastri, Shetty Prakash, Moiyadi Aliasgar, Gupta Tejpal, Jalali Rakesh, Epari Sridh |
- Page last reviewed:Mar 16, 2019
- Page last updated:Sep 18, 2020
- Content source: